Skip to main content

Interviews

Anant Ramaswamy, MD, Tata Memorial Hospital
Videos
01/20/2024
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses...
01/20/2024
Oncology
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center
Videos
01/19/2024
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed...
01/19/2024
Oncology
Live From Expo 2023: Peter Antevy and Charlie Coyle on the Wall Time Problem
Podcasts
10/27/2023
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the...
10/27/2023
EMSWorld
Windy Cole, DPM
Podcasts
10/27/2023
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain...
10/27/2023
Podiatry Today
Dr. Nair and Schloss
Podcasts
10/23/2023
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit...
10/23/2023
EP Lab Digest
Bradley Monk, MD, University of Arizona School of Medicine
Videos
08/02/2023
Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.
Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.
Bradley Monk, MD, discusses the...
08/02/2023
Oncology
Lucjan Wyrwicz, MD, Maria Sklodowska Curie National Cancer Research Institute
Videos
07/12/2023
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on...
07/12/2023
Oncology
James Harding, MD, Memorial Sloan Kettering Cancer Center
Videos
07/12/2023
According to a study presented at the 2023 World Congress on Gastrointestinal Cancers, the IDH1/2-inhibitor LY3410738 showed promising efficacy and safety in combination with chemotherapy for patients with locally advanced or metastatic...
According to a study presented at the 2023 World Congress on Gastrointestinal Cancers, the IDH1/2-inhibitor LY3410738 showed promising efficacy and safety in combination with chemotherapy for patients with locally advanced or metastatic...
According to a study presented...
07/12/2023
Oncology
Javier Cortes, MD, PhD, International Breast Cancer Center, Madrid, Spain
Videos
06/21/2023
Javier Cortes, MD, PhD, discusses results from the PHERGain study, evaluating chemotherapy de-escalation strategies in HER2-positive early breast cancer, presented at the 2023 ASCO Annual Meeting.
Javier Cortes, MD, PhD, discusses results from the PHERGain study, evaluating chemotherapy de-escalation strategies in HER2-positive early breast cancer, presented at the 2023 ASCO Annual Meeting.
Javier Cortes, MD, PhD,...
06/21/2023
Oncology
Lars Henrik Jensen, MD, University Hospital of Southern Denmark
Videos
06/14/2023
On site at ASCO 2023, Dr Lars Henrik Jensen shares results from the phase 3 NeoCol trial evaluating the addition of neoadjuvant chemotherapy to initial surgery for patients with locally advanced colon cancer.
On site at ASCO 2023, Dr Lars Henrik Jensen shares results from the phase 3 NeoCol trial evaluating the addition of neoadjuvant chemotherapy to initial surgery for patients with locally advanced colon cancer.
On site at ASCO 2023, Dr Lars...
06/14/2023
Oncology